A positive association between leptin and blood pressure of normal range in Japanese men

Hypertension Research

Volumn 29, Issue 7, 2006, Pages 485-492

  Wada, Keiko ^a   Yatsuka, Hiroshi ^a   Tamakoshi, Koji ^a   Otsuka, Rei ^a   Fujii, Chie ^a   Matsushita, Kunihiro ^a   Sugiura, Kaichiro ^a   Toyoshima, Hideaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood pressure; Body mass index; Epidemiology; Insulin resistance; Leptin

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTERY TONE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRINKING BEHAVIOR; HUMAN; INSULIN RESISTANCE; JAPAN; MALE; OBESITY; PHYSICAL ACTIVITY; SMOKING HABIT; STANDARDIZATION; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGING; ALCOHOL DRINKING; ANTHROPOMETRY; BLOOD PRESSURE; BODY MASS INDEX; COHORT STUDIES; HOMEOSTASIS; HUMANS; INSULIN; JAPAN; LEPTIN; LIFE STYLE; MALE; REFERENCE VALUES; REGRESSION ANALYSIS; SMOKING;

EID: 33748556217     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.485     Document Type: Article

References (54)

1. Montani JP, Antic V, Yang Z, Dulloo A: Pathways from obesity to hypertension: from the perspective of a vicious triangle. Int J Obes Relat Metab Disord 2002; 26: S28-S38.
2. Aihara A, Imai Y, Sekino M, et al: Discrepancy between screening blood pressure and ambulatory blood pressure: a community-based study in Ohasama. Hypertens Res 1998; 21: 127-136.
3. Masuo K, Mikami H, Ogihara T, Tuck ML: Weight gain-induced blood pressure elevation. Hypertension 2000; 35: 1135-1140.
4. Flaa A, Mundal HH, Eide I, Kjeldsen S, Rostrup M: Sympathetic activity and cardiovascular risk factors in young men in the low, normal, and high blood pressure ranges. Hypertension 2006; 47: 396-402.
5. Kaushik RM, Mahajan SK, Rajesh V, Kaushik R: Stress profile in essential hypertension. Hypertens Res 2004; 27: 619-624.
6. Shek EW, Brands MW, Hall JE: Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31: 409-414.
7. Casto RM, VanNess JM, Overton JM: Effects of central leptin administration on blood pressure in normotensive rats. Neurosci Lett 1998; 246: 29-32.
8. Agata J, Masuda A, Takada M, et al: High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 1997; 10: 1171-1174.
9. Shen WHH, Lee WJ, Chen YT: High plasma leptin concentrations in hypertensive men but not in hypertensive women. J Hypertens 1999; 17: 1289-1295.
10. de Courten M, Zimmet P, Hodge A, et al: Hyperleptinaemia: the missing link in the metabolic syndrome? Diabet Med 1997; 14: 200-208.
11. Barba G, Russo O, Siani A, et al: Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern. Obes Res 2003; 11: 160-166.
12. Hirose H, Saito I, Tsujioka M, Mori M, Kawabe H, Saruta T: The obese gene product, leptin: possible role in obesity-related hypertension in adolescents. J Hypertens 1998; 16: 2007-2012.
13. Takizawa H, Ura N, Saitoh S, et al: Gender difference in the relationships among hyperleptinernia, hyperinsulinemia, and hypertension. Clin Exp Hypertens 2001; 23: 357-368.
14. Itoh K, Imai K, Masuda T, et al: Relationship between changes in serum leptin levels and blood pressure after weight loss. Hypertens Res 2002; 25: 881-886.
15. Hu FB, Chen C, Wang B, Stampfer MJ, Xu X: Leptin concentrations in relation to overall adiposity, fat distribution, and blood pressure in a rural Chinese population. Int J Obes Relat Metab Disord 2001; 25: 121-125.
16. El-Gharbawy AH, Kotchen JM, Grim CE, et al: Gender-specific correlates of leptin with hypertension-related phenotypes in African Americans. Am J Hypertens 2002; 15: 989-993.
17. Mallamaci F, Cuzzola F, Tripepi G, et al: Gender-dependent differences in plasma leptin in essential hypertension. Am J Hypertens 2000; 13: 914-920.
18. Aizawa-Abe M, Ogawa Y, Masuzaki H, et al: Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 2000; 105: 1243-1252.
19. Sung KC, Kim BJ, Kim BS, et al: In normoglycemic Koreans, insulin resistance and adipocity are independently correlated with high blood pressure. Circ J 2004; 68: 898-902.
20. Verma S, Bhanot S, McNeill JH: Sympathectomy prevents fructose-induced hyperinsulinemia and hypertension. Eur J Pharmacol 1999; 373: R1-R4.
21. Galipeau D, Arikawa E, Sekirov I, McNeill JH: Chronic thromboxane synthase inhibition prevents fructose-induced hypertension. Hypertension 2001; 38: 872-876.
22. Vecchione C, Aretini A, Maffei A, et al: Cooperation between insulin and leptin in the modulation of vascular tone. Hypertension 2003; 42: 166-170.
23. Kolaczynski JW, Nyce MR, Considine RV, et al: Acute and chronic effects of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes 1996; 45: 699-701.
24. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI: Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 100: 270-278.
25. Fruhbeck G: Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 1999; 48: 903-908.
26. Matsuda K, Teragawa H, Fukuda Y, Nakagawa K, Higashi Y, Chayama K: Leptin causes nitric-oxide independent coronary artery vasodilation in humans. Hypertens Res 2003; 26: 147-152.
27. Zanetti M, Barazzoni R, Vadori M, Stebel M, Biolo G, Guamieri G: Lack of direct effect of moderate hyperleptinemia to improve endothelial function in lean rat aorta: role of calorie restriction. Atherosclerosis 2004; 175: 253-259.
28. Beltowski J, Wojcicka G, Jamroz A: Stimulatory effect of leptin on nitric oxide production is impaired in dietary-induced obesity. Obes Res 2003; 11: 1571-1580.
29. Yatsuya H, Tamakoshi K, Hattori H, et al: Serum phospholipid transfer protein mass as a possible protective factor for coronary heart diseases. Circ J 2004; 68: 11-16.
30. Mabuchi T, Yatsuya H, Tamakoshi K, et al: Association between serum leptin concentration and white blood cell count in middle-aged Japanese men and women. Diabetes Metab Res Rev 2005; 21: 441-447.
31. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
32. European Society of Hypertension-European Society of Cardiology Guidelines Committee: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053.
33. Japanese Society of Hypertension Guidelines Subcommitee for the Management of Hypertension: Guidelines for the management of hypertension for general practitioners. Hypertens Res 2001; 24: 613-634.
34. Kim-Motoyama H, Yamaguchi T, Katakura T, et al: Serum leptin levels are associated with hyperinsulinemia independent of body mass index but not with visceral obesity. Biochem Biophys Res Commun 1997; 239: 340-344.
35. Zimmet PZ, Collins VR, de Courten MP, et al, Mauritius NCD Study Group: Is there a relationship between leptin and insulin sensitivity independent of obesity? A population-based study in the Indian Ocean nation of Mauritius. Int J Obes Relat Metab Disord 1998; 22: 171-177.
36. Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M: Plasma leptin and insulin relationships in obese and non-obese humans. Diabetes 1996; 45: 695-698.
37. Mark AL, Shaffer RA, Correia ML, Morgan DA, Sigmund CD, Haynes WG: Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J Hypertens 1999; 17: 1949-1953.
38. Bornstein SR, Torpy DJ: Leptin and the renin-angiotensin-aldosterone system. Hypertension 1998; 32: 376-377.
39. Jackson EK, Li P: Human leptin has natriuretic activity in the rat. Am J Physiol 1997; 272: F333-F338.
40. Suter PM, Locher R, Hasler E, Vetter W: Is there a role for the ob gene product leptin in essential hypertension? Am J Hypertens 1998; 11: 1305-1311.
41. Corica F, Corsonello A, Ientile R, et al: Leptin and norepinephrine plasma concentrations during glucose loading in normotensive and hypertensive obese women. Am J Hypertens 2001; 14: 619-626.
42. Eikelis N, Schlaich M, Aggarwal A, Kaye D, Esler M: Interactions between leptin and the human sympathetic nervous system. Hypertension 2003; 41: 1072-1079.
43. Narkiewicz K, Kato M, Phillips BG, et al: Leptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects. J Hypertens 2001; 19: 1089-1094.
44. Fogari R, Derosa G, Zoppi A, et al: Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients. Hypertens Res 2005; 28: 209-214.
45. Nishina M, Kikuchi T, Yamazaki H, Kameda K, Hiura M, Uchiyama M: Relationship among systolic blood pressure, serum insulin and leptin, and visceral fat accumulation in obese children. Hypertens Res 2003; 26: 281-288.
46. Tank J, Jordan J, Diedrich A, et al: Bound leptin and sympathetic outflow in nonobese men. J Clin Endocrinol Metab 2003; 88: 4955-4959.
47. Sinha MK, Opentanova I, Ohannesian JP, et al: Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 1996; 98: 1277-1282.
48. Sandhofer A, Laimer M, Ebenbichler CF, Kaser S, Paulweber B, Patsch JR: Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome. Obes Res 2003; 11: 760-768.
49. Knudson JD, Dincer UD, Zhang C, et al: Leptin receptors are expressed in coronary arteries and hyperleptinemia causes significant coronary endothelial dysfunction. Am J Physiol Heart Circ Physiol 2005; 289: H48-H56.
50. Smulyan H, Safar ME: The diastolic blood pressure in systolic hypertension. Ann Intern Med 2000; 132: 233-237.
51. Kirpichnikov D, Sowers JR: Role of ACE inhibitors in treating hypertensive diabetic patients. Curr Diab Rep 2002; 2: 251-257.
52. Imazu M: Hypertension and insulin disorders. Curr hypertens Rep 2002; 4: 477-482.
53. Bonora E, Targher G, Alberiche M, et al: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63.
54. Haffner SM, Gingerich RL, Miettinen H, Stem MP: Leptin concentrations in relation to overall adiposity and regional body fat distribution in Mexican Americans. Int J Obes Relat Metab Disord 1996; 20: 904-908.